Saptaparna Mukherjee
Rehovot, M 76100, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
KRAS Inhibitor-Induced Cancer Cell Death Enhances Sensitivity to Immune-Mediated Bystander Killing of Drug-Resistant Subclones.
Journal: Cancer research
Published: December 12, 2025
Sensitizing Immune-Refractory Ovarian Tumors via p53 Mutation-Tailored Immunotherapy.
Journal: bioRxiv : the preprint server for biology
Published: July 16, 2025
Author Correction: Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis.
Journal: Nature communications
Published: January 10, 2023
Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.
Journal: Molecular systems biology
Published: September 12, 2022
TAZ facilitates breast tumor growth by promoting an immune-suppressive tumor microenvironment.
Journal: Molecular oncology
Published: August 26, 2022
Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 19, 2022
Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis.
Journal: Nature communications
Published: January 12, 2022
TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 05, 2021
Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients.
Journal: Nature communications
Published: May 26, 2021
Transcriptional profiling reveals a subset of human breast tumors that retain wt TP53 but display mutant p53-associated features.
Journal: Molecular oncology
Published: April 01, 2020
Last Updated: 09/26/2026